ICD-10 Coding for Warfarin Therapy Management(D68.32, D68.32U, D68.9)
Explore detailed ICD-10 coding guidelines for warfarin therapy, including subtherapeutic INR and long-term anticoagulation management.
Complete code families applicable to Warfarin Therapy Management
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R79.8 | Other specified abnormal findings of blood chemistry | Use when the patient is admitted for management of subtherapeutic INR without bleeding or thrombosis. |
|
| Z79.01 | Long term (current) use of anticoagulants | Use for patients on long-term anticoagulation therapy without acute conditions. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutWarfarin Therapy Management
Alternative codes to consider when ruling out similar conditions
Use when there is bleeding due to anticoagulant therapy.
Use for bridging therapy documentation.
Documentation & Coding Risks
Avoid these common issues when documenting Warfarin Therapy Management.
Failing to document INR values
Impact
Clinical: Inadequate monitoring of anticoagulation therapy., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.
Mitigation
Implement INR documentation protocols., Regular training on anticoagulation management.
Using D68.9 for patients on anticoagulants
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Mitigation
Use Z79.01 instead to indicate long-term anticoagulant use.
INR Documentation
Impact
Lack of precise INR documentation can lead to audit issues.
Mitigation
Ensure all INR values are documented and linked to treatment decisions.